On October 27, 2015, the 10th subject was enrolled in our ongoing study of MDMA-assisted therapy for social anxiety in 12 adults on the autism spectrum. Sponsored by MAPS, this is a collaborative study between MAPS and the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, with blood plasma biomarker analysis being conducted by researchers at Stanford University. “The treatment is provided within the context of ongoing therapy over several months,” write Principal Investigator Charles Grob, M.D., and Co-Investigator Alicia Danforth, Ph.D., in their upcoming report for the Winter 2015 MAPS Bulletin. “Which means that study participants need to reside within a 30-mile radius of the study location, which has slowed the screening process a bit. However, the widespread interest is encouraging, and we anticipate completing enrollment by winter 2015.”
